{{Rsnum
|rsid=2018683
|Chromosome=7
|position=28974579
|Orientation=plus
|GMAF=0.3976
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 18.8 | 48.2 | 33.0
| HCB | 54.0 | 38.7 | 7.3
| JPT | 41.6 | 46.0 | 12.4
| YRI | 69.4 | 26.5 | 4.1
| ASW | 56.1 | 38.6 | 5.3
| CHB | 54.0 | 38.7 | 7.3
| CHD | 56.5 | 38.0 | 5.6
| GIH | 34.7 | 44.6 | 20.8
| LWK | 60.9 | 32.7 | 6.4
| MEX | 24.6 | 59.6 | 15.8
| MKK | 57.1 | 32.1 | 10.9
| TSI | 20.6 | 45.1 | 34.3
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23478653
  |Trait=Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
  |Title=A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.
  |RiskAllele=T
  |Pval=8E-7
  |OR=7.80
  |ORtxt=[3.4-17.7]
  }}

{{on chip | Affy GenomeWide 6}}